Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

candesartan MeSH Supplementary Concept Data 2025


MeSH Supplementary
candesartan
Unique ID
C081643
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C081643
Entry Term(s)
2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-benzimidazole-7-carboxylic acid
2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
CV 11974
CV-11974
CV11974
Pharm Action
Antihypertensive Agents
Angiotensin II Type 1 Receptor Blockers
Registry Numbers
S8Q36MD2XX
Related Numbers
139481-59-7
Heading Mapped to
*Benzimidazoles
*Biphenyl Compounds
*Tetrazoles
Frequency
1884
Note
a nonpeptide angiotensin II receptor antagonist
Source
Eur J Pharmacol 1993 Apr 28;235(2-3):313-6
Date of Entry
1993/07/12
Revision Date
2021/02/18
candesartan Preferred
CV 11974 Narrower
page delivered in 0.004s